多发性骨髓瘤的治疗:对T细胞功能的影响是什么?
Chenggong Li1,2, Xindi Wang3,4, Jia Xu3,4
1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan 430022, China.
多发性骨髓瘤的治疗方法已经进步,但癌症仍然无法治愈. 本综述探讨了疗法如何影响T细胞功能,并提出了增强T细胞对多发性骨髓瘤免疫力的策略.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 多发性骨髓瘤 (MM) 治疗通过干细胞移植,蛋白酶体抑制剂,免疫调节药物和单克隆抗体等疗法显著改善了预后.
- 新兴的治疗方法包括CAR-T细胞,双特异性T细胞参与剂和抗体-药物联合体提供了新的治疗途径.
- 尽管有进展,多发性骨髓瘤仍然是一个无法治愈的恶性瘤,强调需要更有效的治疗策略.
研究的目的:
- 审查当前和新型抗髓瘤药物对T细胞功能的影响.
- 通过增强T细胞免疫力来优化多发性骨髓瘤管理的策略.
主要方法:
- 关于多发性骨髓瘤治疗现有研究的文献综述.
- 在多发性骨髓瘤的背景下,分析各种治疗剂对T细胞功能的影响.
- 综合发现,提出优化治疗策略.
主要成果:
- 包括新型疗法在内的各种抗髓瘤药物对T细胞功能产生不同的影响.
- T细胞功能障碍是克服多发性骨髓瘤的一个重要障碍.
- 增强T细胞免疫力是改善治疗结果的有希望的方法.
结论:
- 优化T细胞功能对于有效的多发性髓瘤治疗至关重要.
- 未来的战略应该集中在利用和促进T细胞免疫力,以对抗多发性骨髓瘤.
- 对于不可治愈的多发性髓瘤,需要对T细胞导向免疫疗法的进一步研究.
更多相关视频
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
相关概念视频
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Differentiation of Common Myeloid Progenitor Cells
